Back to search
Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a Phase 1b/2 study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting cluster of diff…
This clinical trial is studying the safety and potential anti-tumor activity of an investigational drug called ARV-393 in patients diagnosed with advanced Relap…